First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-03-19 09:50:43Open Document File Size: 111,12 KBShare Result on FacebookCityKansas City / /CompanyPluristem Therapeutics Inc. / Charles River Labs / Boston Biomedica Inc. / MDS Capital Management / PriMed / MdBio / Panacos Inc. / Prosensa Holdings / Bayer Healthcare Receives / /CountryJapan / /EventBusiness Partnership / /FacilityUniversity of Missouri / Harvard University / /IndustryTermpublic pharmaceutical / prevention of stroke / healthcare venture / /MedicalConditionStrokes / animal’s high blood pressure / placental-based disorder / obesity / disorder / clinical journal Stroke / preeclampsia doubles / hypertension / disease / stroke / pulmonary hypertension / high blood pressure / uniquely female disease / eclamptic seizures / preeclampsia / hypercholesterolemia / disorders / /MedicalTreatmentcell therapy / /OrganizationHarvard University / Stroke Center / Wake Forest Baptist Medical Center / University of Missouri / American Stroke Association / Texas A&M / FDA / American Heart Association / Clinical Advisory Board / Stroke Center at Wake Forest Baptist Medical Center / /PersonWilliam R. Prather / Brent Mitchell / Cheryl Bushnell / Cancer Gold / /PositionChair of the committee / physician / Author / CEO / Director / Sr. VP Corporate Development / VP Corporate Development / Registered Pharmacist / animal model / co-founder / /Productmagnesium sulfate / /ProvinceOrStateMaryland / Missouri / /TechnologyCell Therapy / /URLhttp /SocialTag |